COMMUNIQUÉS West-GlobeNewswire

Lexicon Pharmaceuticals Announces Poster Presentation at ASCO GI

02/01/2018 - 22:01

THE WOODLANDS, Texas, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), announced today that data from a poster highlighting XERMELO ® (telotristat ethyl) will be presented at the upcoming [...]

Atara Biotherapeutics Announces Proposed Offering of Common Stock

02/01/2018 - 22:01

SOUTH SAN FRANCISCO, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]

Mesa Labs Declares Quarterly Dividend

02/01/2018 - 21:34

Lakewood, CO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB ) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0. [...]

Elite Pharmaceuticals Announces FDA Approval of Phendimetrazine Tartrate Tablets USP

02/01/2018 - 18:56

NORTHVALE, N.J., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP ) a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]

Transactions concluded by management

02/01/2018 - 16:47

Olaine, 2018-01-02 16:47 CET (GLOBE NEWSWIRE) -- AS Olainfarm has received the notification of manager on transactions with securities issued by AS Olainfarm. The received notification is available in attachment. [...]

American Health Council’s Honors Charles Tucker DNP, MSN, RN, CNE as “Best in Nursing”

02/01/2018 - 16:09

NEW YORK, Jan. 02, 2018 (GLOBE NEWSWIRE) -- The American Health Council honors accomplished clinician and Associate Professor of Nursing Charles Tucker DNP, MSN, RN, CNE as one of America’s “Best in Nursing.” Dr. Tucker [...]

Hemispherx Biopharma CEO Discusses 2017 Highlights on CEOLIVE.TV

02/01/2018 - 16:08

ORLANDO, Fla., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), based in Orlando, FL, focused on pharmaceuticals, today announced that Thomas K. Equels, M.S. J.D., Chief Executive [...]

AIT Therapeutics Appoints Yoori Lee to its Board of Directors

02/01/2018 - 15:45

Seasoned veteran with decades of strategic, scientific, clinical and leadership experience NEW YORK, Jan. 02, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused [...]

UroGen Pharma to Present at the 36th Annual J.P. Morgan Healthcare Conference

02/01/2018 - 14:00

RA’ANANA, Israel and NEW YORK, Jan. 02, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]

Optinose Announces $100 Million Debt Financing from Athyrium Capital Management

02/01/2018 - 14:00

YARDLEY, Pa., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that it has entered [...]

Intra-Cellular Therapies to Present at the 36th Annual J.P. Morgan Healthcare Conference

02/01/2018 - 14:00

NEW YORK, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

Sorrento Therapeutics to Present Potential “Game-Changer” Non-Viral CAR-T Technology for Autologous and Allogeneic (off-the-shelf) CAR-T Therapies

02/01/2018 - 14:00

SAN DIEGO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (“Sorrento” or the “Company”) (NASDAQ: SRNE ) announced today that Dr. Henry Ji, Chairman & CEO of Sorrento, will share recent Sorrento [...]

Vericel Initiates Collaboration with Innovative Cellular Therapeutics

02/01/2018 - 14:00

CAMBRIDGE, Mass. and SHANGHAI, China, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases [...]

Biotricity Announces Expansion of Bioflux Sales Force and Pilot Sites

02/01/2018 - 14:00

REDWOOD CITY, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]

India Globalization Capital Reports Promising Spatial Memory Results in Alzheimer’s Study

02/01/2018 - 14:00

BETHESDA, Md., Jan. 02, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) provides compelling in vivo data compiled from genetically engineered mice to mimic Alzheimer’s shows marked improvement [...]

Atara Biotherapeutics Announces Initiation of Two Phase 3 Clinical Studies to Evaluate Tabelecleucel in Patients with Rituximab-Refractory Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder (EBV+PTLD)

02/01/2018 - 14:00

– Three clinical sites for both the MATCH and ALLELE pivotal studies now open for enrollment in the U.S. – SOUTH SAN FRANCISCO, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a [...]

Inovalon to Present at 36th Annual J.P. Morgan Healthcare Conference

02/01/2018 - 13:55

BOWIE, Md., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]

Arch Therapeutics to Provide Corporate Update at The 10th Annual Biotech Showcase™ 2018 Conference on January 8th, 2018

02/01/2018 - 13:50

FRAMINGHAM, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]

Merus to Present at the 36th Annual J.P. Morgan Healthcare Conference

02/01/2018 - 13:30

UTRECHT, The Netherlands, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that Ton [...]